PMD Solutions is a pioneering biotechnology and health care startup established in 2011 in Ireland. The company’s mission is encapsulated in its slogan, "Making every breath count with our revolutionary RespiraSense continuous respiratory rate monitoring." Recognizing the critical clinical need to address respiratory failure among compromised patient populations, PMD Solutions developed RespiraSense, a ground-breaking wireless, discreet, and continuous respiratory rate monitor. This standout innovation eliminates subjectivity in respiratory rate monitoring, delivering vital information efficiently through a user-friendly platform. Notably, the creation of RespiraSense has revolutionized early diagnosis and intervention in medical events, effectively emphasizing the company's commitment to making every breath count. The company received non-equity assistance investment from DigitalHealth.London on 03 July 2023, underlining its appeal to investment entities recognizing its potential impact and growth within the industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | 03 Jul 2023 | |
Venture Round | €1.40M | - | 13 Jan 2020 | |
Grant | £63.67K | 1 | 31 Jan 2017 | |
Grant | €4.27M | 1 | EASME - EU Executive Agency for SMEs | 01 Apr 2016 |
Series A | €4.27M | 1 | EASME - EU Executive Agency for SMEs | 08 Nov 2015 |
No recent news or press coverage available for PMD Solutions.